Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Elosulfase Alfa in Morquio A Syndrome
NCT01415427Phase 3Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Jul 2011
- Primary completion
- Jun 2016
- Modality
- Replacement Enzymes
- Countries
- 20
01
Overview
A Phase 3 trial of elosulfase alfa in Mucopolysaccharidosis type IV A, sponsored by BioMarin Pharmaceutical. Started Jul 2011; status: completed.
02
Drugs
elosulfase alfa
03
Conditions
Mucopolysaccharidosis type IV A
Beyond the preview
Go deeper on NCT01415427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01415427.